Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Asia
Pharma
Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia
Eisai and Biogen's second Alzheimer's drug returns a victory. Astellas and Pfizer fight over a Lexiscan generic. Novartis sells a Sandoz plant.
Angus Liu
Sep 30, 2022 9:15am
Novartis' spinoff-headed Sandoz sells Chinese plant for $15.1M
Sep 28, 2022 10:32am
Asymchem Labs in early planning for $697M manufacturing facility
Sep 27, 2022 9:51am
WuXi expansion tear continues with new oral production plant
Sep 27, 2022 8:45am
Daiichi Sankyo bags an industry first for blood cancer drug
Sep 26, 2022 11:02am
Moderna, Takeda and Everest—Fierce Pharma Asia
Sep 23, 2022 9:25am
